Company

Cardiola Ltd., based in Switzerland, has developed a completely new and highly-effective option for treating chronic heart failure.

Review our company’s profile and development. Assess the innovative treatment made possible with the Muscular Counter Pulsation (MCP) and the treatment successes now being documented with this technology. And learn why the new MCP device class has the potential to command a completely new market segment.